ArticleExploratory research in clinical and social pharmacy2026
Beyond descriptive SWOT in pharmacy strategy: A quantitative framework for leaders, managers and educators from prioritization to strategic response.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis is widely used in pharmacy strategy because it is simple, familiar, and adaptable across practice, education, and management settings. However, descriptive SWOT often stops at factor identification, offering limited support for prioritization, stakeholder comparison, and strategic action in multi-stakeholder pharmacy contexts. This article develops a conceptual-methodological framework for advancing SWOT through quantification, stakeholder-sensitive comparison and strategic translation. An illustrative mixed-methods university-industry pharmacy education application is used only to demonstrate operationalization of the framework, serving as a methodological example rather than a definitive evaluation of a local program. The framework advances descriptive SWOT through five stages. First, SWOT defines the focal strategic profile. Second, broader macro-context is distinguished from organization- or program-specific diagnosis through Political, Economic, Social, Technological, Environmental, and Legal (PESTEL) analysis. Third, factor importance is quantified using analysis-appropriate methods, ranging from ordinal rating and continuous scoring to weighting, sensitivity analysis, or uncertainty-sensitive approaches. Fourth, gap analysis identifies alignment or separation in how groups prioritize the same factors. Fifth, strategic response is developed through Threats, Opportunities, Weaknesses, and Strengths (TOWS) matrix translation, converting selected quantified findings into growth, reinforcement, defensive, and risk-reduction strategic options. Overall, the framework advances SWOT from strategic diagnosis to measurable strategic response by integrating qualitative contextual mapping with structured measurement and analysis within a transparent, comparative, and decision-relevant pathway. It offers pharmacy leaders, managers, and educators a scalable approach for moving from descriptive SWOT toward prioritized and action-oriented strategic planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.